NEXGEL (NASDAQ:NXGL – Get Free Report) will be releasing its earnings data before the market opens on Thursday, November 14th.
NEXGEL (NASDAQ:NXGL – Get Free Report) last posted its earnings results on Monday, August 19th. The company reported ($0.14) EPS for the quarter. NEXGEL had a negative return on equity of 64.21% and a negative net margin of 67.80%. The firm had revenue of $1.44 million for the quarter.
NEXGEL Stock Performance
NXGL opened at $2.87 on Thursday. The business’s 50-day simple moving average is $2.76 and its 200-day simple moving average is $2.50. The company has a current ratio of 1.36, a quick ratio of 0.81 and a debt-to-equity ratio of 0.22. NEXGEL has a one year low of $1.65 and a one year high of $3.24.
About NEXGEL
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Featured Articles
- Five stocks we like better than NEXGEL
- Overbought Stocks Explained: Should You Trade Them?
- What a Trump Win Looks Like for the Market Now and Into 2025
- What is a Dividend King?
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Which Wall Street Analysts are the Most Accurate?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.
